CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors.
Shashi Nayana MR, Sekhar YN, Siva Kumari N, Mahmood SK, Ravikumar M, Eur J Med Chem, 2008 Jun - link